UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.045

Sortiert nach

Preparing serum for functional complement assays

Journal of immunological methods, 2010-01, Vol.352 (1), p.195-197

Lachmann, P.J.

2010

Volltextzugriff (PDF)

The penumbra of thalidomide, the litigation culture and the licensing of pharmaceuticals

QJM : An International Journal of Medicine, 2012-12, Vol.105 (12), p.1179-1189

LACHMANN, P. J

2012

Volltextzugriff (PDF)

Systemic lupus erythematosus, complement deficiency, and apoptosis

Advances in Immunology, 2001-01, Vol.76, p.227-324

2001

Volltextzugriff (PDF)

Antimicrobial peptides: mediators of innate immunity as templates for the development of novel anti-infective and immune therapeutics

Current pharmaceutical design, 2004-09, Vol.10 (23), p.2891

2004

Volltextzugriff (PDF)

Primary pneumococcal peritonitis can be the first presentation of a familial complement factor I deficiency1

Clinical and experimental immunology, 2020-12, Vol.202 (3), p.379-383

2020

Volltextzugriff (PDF)

Further studies of the down‐regulation by Factor I of the C3b feedback cycle using endotoxin as a soluble activator and red cells as a source of CR1 on sera of different complotype

Clinical and experimental immunology, 2016-01, Vol.183 (1), p.150-156

2016

Volltextzugriff (PDF)

Complotype affects the extent of down‐regulation by Factor I of the C3b feedback cycle in vitro

Clinical and experimental immunology, 2015-08, Vol.181 (2), p.314-322

2015

Volltextzugriff (PDF)

Taking Complement to the Clinic - has the Time Finally Come?

Scandinavian journal of immunology, 2009-06, Vol.69 (6), p.471-478

2009

Volltextzugriff (PDF)

Microbial Subversion of the Immune Response

Proceedings of the National Academy of Sciences - PNAS, 2002-06, Vol.99 (13), p.8461-8462

Lachmann, P. J.

2002

Volltextzugriff (PDF)

Measurement of deoxyribonuclease I (DNase) in the serum and urine of systemic lupus erythematosus (SLE)‐prone NZB/NZW mice by a new radial enzyme diffusion assay

Clinical and experimental immunology, 1997-05, Vol.108 (2), p.220-226

1997

Volltextzugriff (PDF)

Bee venom immunotherapy induces a shift in cytokine responses from a TH-2 to a TH-1 dominant pattern: comparison of rush and conventional immunotherapy

Clinical and experimental allergy, 1995-09, Vol.25 (9), p.828-838

1995

Volltextzugriff (PDF)

The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen‐ and antigen‐stimulated human peripheral blood mononuclear cell cultures

Clinical and experimental immunology, 1995-02, Vol.99 (2), p.160-167

1995

Volltextzugriff (PDF)

Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11a/CD18 (LFA-1) on NK cells

The Journal of clinical investigation, 1996-12, Vol.98 (12), p.2819-2826

1996

Volltextzugriff (PDF)

CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells

The Journal of experimental medicine, 1989-09, Vol.170 (3), p.637-654

1989

Volltextzugriff (PDF)

Interaction between Host Complement and Mosquito-Midgut-Stage Plasmodium berghei

Infection and Immunity, 2001-08, Vol.69 (8), p.5064-5071

2001

Volltextzugriff (PDF)

Lupus and desoxyribonuclease

Lupus, 2003-03, Vol.12 (3), p.202-206

Lachmann, P J

2003

Volltextzugriff (PDF)

Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell

Journal of Virology, 1994-12, Vol.68 (12), p.8001-8007

1994

Volltextzugriff (PDF)

Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers

Immunology, 1990-09, Vol.71 (1), p.1-9

1990

Volltextzugriff (PDF)

Streptococcal Inhibitor of Complement Inhibits Two Additional Components of the Mucosal Innate Immune System: Secretory Leukocyte Proteinase Inhibitor and Lysozyme

Infection and Immunity, 2002-09, Vol.70 (9), p.4908-4916

2002

Volltextzugriff (PDF)

Subversion of the innate immune response by micro-organisms

Annals of the rheumatic diseases, 2002-11, Vol.61 (suppl 2), p.ii8-12

2002

Volltextzugriff (PDF)

Consent and confidentiality—where are the limits? An introduction

Journal of medical ethics, 2003-02, Vol.29 (1), p.2-3

Lachmann, P J

2003

Volltextzugriff (PDF)

The interaction of streptococcal inhibitor of complement (SIC) and its proteolytic fragments with the human beta defensins

Immunology, 2004-04, Vol.111 (4), p.444-452

2004

Volltextzugriff (PDF)

Britain's Academy of Medical Sciences has been busy in recent months [letter]

BMJ. British medical journal (International ed.), 1999-06, Vol.318 (7198), p.1624

Lachmann, P

International edition, 1999

Volltextzugriff (PDF)

Complement before molecular biology

Molecular immunology, 2006-02, Vol.43 (6), p.496-508

Lachmann, Peter

2006

Volltextzugriff (PDF)

Streptococcal inhibitor of complement (SIC) inhibits the membrane attack complex by preventing uptake of C567 onto cell membranes

Immunology, 2001-07, Vol.103 (3), p.390-398

2001

Volltextzugriff (PDF)

1 – 25 von 1.045

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(884)
Mit Volltextzugriff
(886)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(535)
Life Sciences & Biomedicine
(485)
Humans
(472)
Animals
(266)
Biological And Medical Sciences
(221)
Male
(192)
Female
(165)
Immunology
(165)
Medical Sciences
(147)
Adult
(107)
Middle Aged
(98)
Fundamental And Applied Biological Sciences. Psychology
(81)
Mice
(73)
Aged
(68)
General & Internal Medicine
(63)
Fundamental Immunology
(55)
Medicine, General & Internal
(51)
Rats
(51)
Rabbits
(50)
Adolescent
(47)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Clinical And Experimental Immunology
(66)
Immunology
(51)
Pediatric Rheumatology Online Journal
(42)
Nature
(22)
The Lancet
(21)
Annals Of The Rheumatic Diseases
(18)
The Journal Of Experimental Medicine
(18)
Blood
(17)
Scandinavian Journal Of Immunology
(17)
The Journal Of Immunology
(17)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Preparing serum for functional complement assays

The penumbra of thalidomide, the litigation culture and the licensing of pharmaceuticals

Systemic lupus erythematosus, complement deficiency, and apoptosis

Antimicrobial peptides: mediators of innate immunity as templates for the development of novel anti-infective and immune therapeutics

Primary pneumococcal peritonitis can be the first presentation of a familial complement factor I deficiency1

Further studies of the down‐regulation by Factor I of the C3b feedback cycle using endotoxin as a soluble activator and red cells as a source of CR1 on sera of different complotype

Complotype affects the extent of down‐regulation by Factor I of the C3b feedback cycle in vitro

Taking Complement to the Clinic - has the Time Finally Come?

Microbial Subversion of the Immune Response

Measurement of deoxyribonuclease I (DNase) in the serum and urine of systemic lupus erythematosus (SLE)‐prone NZB/NZW mice by a new radial enzyme diffusion assay

Bee venom immunotherapy induces a shift in cytokine responses from a TH-2 to a TH-1 dominant pattern: comparison of rush and conventional immunotherapy

The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen‐ and antigen‐stimulated human peripheral blood mononuclear cell cultures

Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11a/CD18 (LFA-1) on NK cells

CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells

Interaction between Host Complement and Mosquito-Midgut-Stage Plasmodium berghei

Lupus and desoxyribonuclease

Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell

Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers

Streptococcal Inhibitor of Complement Inhibits Two Additional Components of the Mucosal Innate Immune System: Secretory Leukocyte Proteinase Inhibitor and Lysozyme

Subversion of the innate immune response by micro-organisms

Consent and confidentiality—where are the limits? An introduction

The interaction of streptococcal inhibitor of complement (SIC) and its proteolytic fragments with the human beta defensins

Britain's Academy of Medical Sciences has been busy in recent months [letter]

Complement before molecular biology

Streptococcal inhibitor of complement (SIC) inhibits the membrane attack complex by preventing uptake of C567 onto cell membranes

Suchergebnisse filtern